US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vanda Pharmaceuticals

4.53

-0.0050-0.11%

Volume:114.42K

Turnover:520.84K

Market Cap:266.68M

PE:-5.94

High:4.60

Open:4.57

Low:4.49

Close:4.53

Loading ...

Overview Company News Filings

Vanda Pharmaceuticals to Announce First Quarter 2025 Financial Results on May 7, 2025

Vanda Pharmaceuticals Inc expected to post a loss of 60 cents a share - Earnings Preview

Vanda Pharmaceuticals Inc - FDA Delays Vanda's Hearing Request on Tradipitant Approvability

THOMSON REUTERS

FDA Bureaucrats Unlawfully Delay Hearing on Vanda Drug and Falsely Blame Commissioner Makary and the reductions in force at FDA

Vanda Pharmaceuticals Announces Presentation at 2025 AAN Annual Meeting

Vanda Pharmaceuticals Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Vanda Pharmaceuticals Seeks US FDA Approval for Bysanti to Treat Schizophrenia, Acute Bipolar I Disorder

MT Newswires Live

Vanda Pharmaceuticals Announces the Submission of an Nda to the FDA for Bysanti™ for the Treatments of Acute Bipolar I Disorder and Schizophrenia

THOMSON REUTERS

Vanda Pharmaceuticals Inc - Results of Phase Iii Study Expected in 2026

THOMSON REUTERS

Vanda Pharmaceuticals Inc - Bysanti Could Be Available in US in 2026

THOMSON REUTERS

Vanda Raises Concerns Over FDA Review Timeline for Motion Sickness Therapy Candidate

MT Newswires Live

US High Growth Tech Stocks With Strong Potential

Simply Wall St.

February 2025 Penny Stocks To Keep An Eye On

Simply Wall St.

Vanda Pharmaceuticals Announces the Publication of an Article Titled "Potential Aso-Based Personalized Treatment for Charcot-Marie-Tooth Disease Type 2S"

THOMSON REUTERS

Vanda Pharmaceuticals announces the publication of an article titled "Potential ASO-based personalized treatment for Charcot-Marie-Tooth disease type 2S"

Vanda Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Vanda Pharmaceuticals: Promising Revenue Growth and Strategic Pipeline Drive Buy Rating

Vanda Pharmaceuticals’ Earnings Call: Mixed Results and Future Optimism

Vanda Pharmaceuticals Inc (VNDA) Q4 2024 Earnings Call Highlights: Revenue Growth Amidst Challenges

Vanda Pharmaceuticals (VNDA) Reports Q4 Loss, Tops Revenue Estimates

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/VNDA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VNDA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VNDA\",,,,,undefined,":{"symbol":"VNDA","market":"US","secType":"STK","nameCN":"Vanda Pharmaceuticals","latestPrice":4.525,"timestamp":1750438591210,"preClose":4.53,"halted":0,"volume":114419,"delay":0,"floatShares":52332871,"shares":58934482,"eps":-0.761213,"marketStatus":"Trading","change":-0.005,"latestTime":"06-20 12:56:34 EDT","open":4.57,"high":4.6,"low":4.49,"amount":520838.5718253,"amplitude":0.024283,"askPrice":4.53,"askSize":326,"bidPrice":4.52,"bidSize":523,"shortable":3,"etf":0,"ttmEps":-0.761213,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1750449600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1144814400000,"exchange":"NASDAQ","adjPreClose":4.53,"postHourTrading":{"tag":"盘后","latestPrice":4.75,"preClose":4.53,"latestTime":"18:29 EDT","volume":4044,"amount":18340.82,"timestamp":1750285749050},"volumeRatio":0.556221,"impliedVol":0.2501,"impliedVolPercentile":0.16},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VNDA\",,,,,undefined,":{"symbol":"VNDA","floatShares":52332871,"roa":"-7.05%","roe":"-8.38%","lyrEps":-0.325026,"volumeRatio":0.556221,"shares":58934482,"dividePrice":0,"high":4.6,"amplitude":0.024283,"preClose":4.53,"low":4.49,"week52Low":3.8092,"pbRate":"0.52","psRate":"1.32","week52High":6.365,"institutionHeld":0.7152,"latestPrice":4.525,"committee":0.232038,"eps":-0.761213,"divideRate":0,"volume":114419,"delay":0,"ttmEps":-0.761213,"open":4.57,"prevYearClose":4.79,"prevWeekClose":4.51,"prevMonthClose":4.34,"prevQuarterClose":4.59,"fiveDayClose":4.63,"twentyDayClose":4.32,"sixtyDayClose":4.81},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VNDA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2532427168","title":"Vanda Pharmaceuticals to Announce First Quarter 2025 Financial Results on May 7, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2532427168","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532427168?lang=en_us&edition=fundamental","pubTime":"2025-05-02 20:46","pubTimestamp":1746189960,"startTime":"0","endTime":"0","summary":"WASHINGTON, May 2, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc.   today announced it will release results for the first quarter 2025 on Wednesday, May 7, 2025, after the market closes.Vanda will host a conference call at 4:30 PM ET on Wednesday, May 7, 2025, during which management will discuss the first quarter 2025 financial results and other corporate activities. To participate in the conference call, please dial 1-800-715-9871  or 1-646-307-1963  and use passcode 9941754.A replay of the call will be available on Wednesday, May 7, 2025, beginning at 8:30 PM ET and will be accessible until Wednesday, May 14, 2025, at 11:59 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 9941754.Corporate Contact:Kevin MoranSenior Vice President, Chief Financial Officer and TreasurerVanda Pharmaceuticals Inc. 202-734-3400 pr@vandapharma.com","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/vanda-pharmaceuticals-announce-first-quarter-124600146.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vanda-pharmaceuticals-announce-first-quarter-124600146.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2532845523","title":"Vanda Pharmaceuticals Inc  expected to post a loss of 60 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2532845523","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532845523?lang=en_us&edition=fundamental","pubTime":"2025-05-02 20:34","pubTimestamp":1746189276,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals Inc  expected to post a loss of60cents a share - Earnings Preview Vanda Pharmaceuticals Inc VNDA.OQ VNDA.O is expected to show a fall in quarterly revenue when it reports  result","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250502:nL8N3RA1OB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA"],"gpt_icon":0},{"id":"2529142657","title":"Vanda Pharmaceuticals Inc - FDA Delays Vanda's Hearing Request on Tradipitant Approvability","url":"https://stock-news.laohu8.com/highlight/detail?id=2529142657","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529142657?lang=en_us&edition=fundamental","pubTime":"2025-04-24 03:52","pubTimestamp":1745437953,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nFWN3R11VY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2529663748","title":"FDA Bureaucrats Unlawfully Delay Hearing on Vanda Drug and Falsely Blame Commissioner Makary and the reductions in force at FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2529663748","media":"PR Newswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529663748?lang=en_us&edition=fundamental","pubTime":"2025-04-24 03:52","pubTimestamp":1745437920,"startTime":"0","endTime":"0","summary":"WASHINGTON, April 23, 2025 /PRNewswire/ --Vanda Pharmaceuticals Inc.   today announced that FDA bureaucrats have committed to delay Vanda's request for a hearing on the approvability of tradipitant for gastroparesis. Rather than take accountability, FDA bureaucrats identify a new scapegoat: newly appointed Commissioner, Dr. Martin Makary, and reductions in force.FDA bureaucrats have created policies to avoid scrutiny of their decision-making by habitually denying hearings. FDA's office of chief counsel and DOJ have repeatedly defended FDA's right to act unlawfully when confronted by federal judges. When considering FDA's delay in resolving Vanda's hearing request in a prior instance, a federal judge pointedly asked FDA whether it was \"conceding that the [HHS] Secretary is presently not complying with the statute,\" and a DOJ lawyer replied, \"Yes, your Honor\".Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to ad","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/fda-bureaucrats-unlawfully-delay-hearing-195200998.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-bureaucrats-unlawfully-delay-hearing-195200998.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"FDA Bureaucrats Unlawfully Delay Hearing on Vanda Drug and Falsely Blame Commissioner Makary and the reductions in force at FDA","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2525017530","title":"Vanda Pharmaceuticals Announces Presentation at 2025 AAN Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2525017530","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525017530?lang=en_us&edition=fundamental","pubTime":"2025-04-07 20:00","pubTimestamp":1744027200,"startTime":"0","endTime":"0","summary":"Presentation Title: \"Translating IGHMBP2 Variants with a CMT2S Patient-specific Organ-on-a-chip Model: Personalized Medicine ASO-based Therapeutic Rescue\" Poster Presentation Session: P-12 Poster Number: 11-017 Presenter: Dr. Sandra Paulina Smieszek, Head of Genetics. This poster describes the data around a novel breakthrough therapeutic  customized to a specific genetic mutation of a patient with Charcot-Marie-Tooth disease type 2S . The effects of VCA-894A were confirmed in Hesperos' Human-on-a-Chipneuromuscular junction model with patient-derived cells where VCA-894A demonstrated significant improvements in neuromuscular function, including reduced muscle fatigue and improved synaptic transmission between motor neurons and skeletal muscle myotubes. The use of a microphysiological system to evaluate the effects of a genetically tailored treatment represents a significant advancement in precision medicine and the use of human relevant methods of evaluation.VCA-894A has been granted an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/vanda-pharmaceuticals-announces-presentation-2025-120000402.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vanda-pharmaceuticals-announces-presentation-2025-120000402.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4178","AAN","VNDA"],"gpt_icon":0},{"id":"2524190192","title":"Vanda Pharmaceuticals Price Target Maintained With a $20.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2524190192","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524190192?lang=en_us&edition=fundamental","pubTime":"2025-04-01 19:57","pubTimestamp":1743508620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VNDA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 01, 2025 07:57 ET (11:57 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA"],"gpt_icon":0},{"id":"2523092860","title":"Vanda Pharmaceuticals Seeks US FDA Approval for Bysanti to Treat Schizophrenia, Acute Bipolar I Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2523092860","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523092860?lang=en_us&edition=fundamental","pubTime":"2025-03-31 22:15","pubTimestamp":1743430536,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals  said Monday that it submitted a new drug application with the US Food and Drug Administration requesting marketing approval for Bysanti to treat acute bipolar I disorder and schizophrenia.The company started a phase 3 study of the drug as a once-daily add-on treatment for major depressive order in Q4, with results expected in 2026.Shares of the company were down 2.1% in recent trading.Price: 4.59, Change: -0.10, Percent Change: -2.13","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","VNDA"],"gpt_icon":0},{"id":"2523945820","title":"Vanda Pharmaceuticals Announces the Submission of an Nda to the FDA for Bysanti™ for the Treatments of Acute Bipolar I Disorder and Schizophrenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2523945820","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523945820?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:00","pubTimestamp":1743422404,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nTUA1BWM8J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2523694581","title":"Vanda Pharmaceuticals Inc - Results of Phase Iii Study Expected in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2523694581","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523694581?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:00","pubTimestamp":1743422404,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nTUA1BWM8J:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VNDA","BK4139"],"gpt_icon":0},{"id":"2523458939","title":"Vanda Pharmaceuticals Inc - Bysanti Could Be Available in US in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2523458939","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523458939?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:00","pubTimestamp":1743422404,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nTUA1BWM8J:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VNDA"],"gpt_icon":0},{"id":"2520058506","title":"Vanda Raises Concerns Over FDA Review Timeline for Motion Sickness Therapy Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2520058506","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520058506?lang=en_us&edition=fundamental","pubTime":"2025-03-18 02:13","pubTimestamp":1742235191,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals  said in a filing Monday that the US Food and Drug Administration's planned review timelines of its new drug application for tradipitant, a motion sickness treatment, goes against the Food Drug and Cosmetic Act.The regulator has set a target decision date of Dec. 30, which is 12 months after the application was submitted and six months later than the statutory deadline, the company added.Vanda called the FDA \"broken\" and \"unaccountable\" for taking longer than expected to review the drug, despite two large clinical studies with 681 participants showing positive results. The trials showed that tradipitant significantly reduced motion-induced vomiting compared to a placebo, the company said.Vanda Pharmaceuticals shares were 2% up in recent trading activity.Price: 5.08, Change: +0.10, Percent Change: +2.01","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","VNDA"],"gpt_icon":0},{"id":"2516725653","title":"US High Growth Tech Stocks With Strong Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2516725653","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516725653?lang=en_us&edition=fundamental","pubTime":"2025-03-01 01:09","pubTimestamp":1740762554,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the United States market has dropped 4.8%, yet it has risen by 15% over the past year, with earnings anticipated to grow by 14% annually in the coming years. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong potential through innovation and adaptability to leverage these market dynamics effectively.Top 10 High Growth Tech Companies In The United States. Overview: Amicus Therapeutics, Inc. is a biotechnology company dedicated to the discovery, development, and delivery of medicines for rare diseases with a market cap of approximately $2.71 billion.Unlock comprehensive insights into our analysis of Amicus Therapeutics stock in this health report.Assess Amicus Therapeutics' past performance with our detailed historical performance reports.Vanda Pharmaceuticals, amidst a challenging regulatory landscape, continues to innova","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/us-high-growth-tech-stocks-170914833.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2065171311.SGD","FOLD","LU2065170008.USD","VNDA","LU2065171402.SGD","BK4139","LU2065169927.USD","KNSA"],"gpt_icon":0},{"id":"2514903870","title":"February 2025 Penny Stocks To Keep An Eye On","url":"https://stock-news.laohu8.com/highlight/detail?id=2514903870","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514903870?lang=en_us&edition=fundamental","pubTime":"2025-02-27 19:05","pubTimestamp":1740654319,"startTime":"0","endTime":"0","summary":"As February 2025 unfolds, the U.S. stock market has shown signs of resilience with the S&P 500 and Nasdaq Composite inching higher after a four-day losing streak, despite ongoing concerns about the economic outlook. In this context, penny stocks—often representing smaller or newer companies—continue to capture investor interest due to their affordability and potential for growth. While traditionally viewed with caution, these stocks can offer unique opportunities when backed by strong financials and solid fundamentals.Click here to see the full list of 732 stocks from our US Penny Stocks screener.Underneath we present a selection of stocks filtered out by our screen.Overview: ATRenew Inc. operates a platform for pre-owned consumer electronics transactions and services in China, with a market cap of approximately $623.33 million.Operations: The company's revenue is derived from its retail electronics segment, generat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/february-2025-penny-stocks-keep-110519303.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BABB","BK4539","RERE","BK4503","BK4213","BK4563","BK4179","BK4076","BK4122","PHX","SB","BK4021","BK4209","NRT","PVL","TTI","VNDA"],"gpt_icon":0},{"id":"2513406647","title":"Vanda Pharmaceuticals Announces the Publication of an Article Titled \"Potential Aso-Based Personalized Treatment for Charcot-Marie-Tooth Disease Type 2S\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2513406647","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513406647?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:00","pubTimestamp":1740398409,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nTUA90VCYV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VNDA"],"gpt_icon":0},{"id":"2513125740","title":"Vanda Pharmaceuticals announces the publication of an article titled \"Potential ASO-based personalized treatment for Charcot-Marie-Tooth disease type 2S\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2513125740","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513125740?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:00","pubTimestamp":1740398400,"startTime":"0","endTime":"0","summary":"WASHINGTON, Feb. 24, 2025 /PRNewswire/ --Vanda Pharmaceuticals Inc.   today announced the publication of an article entitled \"Potential ASO-based personalized treatment for Charcot-Marie-Tooth disease type 2S\" in Molecular Therapy Nucleic Acids1, a Cell Press partner journal, that describes the development of a novel antisense oligonucleotide  therapeutic, VCA-894A, for a patient with a rare variant in the IGHMBP2 gene causing Charcot-Marie-Tooth disease Type 2S .The article1 published today discusses the development of this novel breakthrough therapeutic customized to a specific genetic mutation of a patient with CMT2S. The effects of VCA-894A were confirmed in Hesperos' Human-on-a-Chip neuromuscular junction model with patient-derived cells where VCA-894A demonstrated significant improvements in neuromuscular function, including reduced muscle fatigue and improved synaptic transmission between motor neurons and skeletal muscle myotubes.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/vanda-pharmaceuticals-announces-publication-article-120000138.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vanda-pharmaceuticals-announces-publication-article-120000138.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CMT","BK4200","BK4090","BK4139","VNDA","BK4561","ASO"],"gpt_icon":0},{"id":"2512962159","title":"Vanda Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2512962159","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512962159?lang=en_us&edition=fundamental","pubTime":"2025-02-18 20:01","pubTimestamp":1739880060,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VNDA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 18, 2025 07:01 ET (12:01 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA"],"gpt_icon":0},{"id":"2512153050","title":"Vanda Pharmaceuticals: Promising Revenue Growth and Strategic Pipeline Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2512153050","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512153050?lang=en_us&edition=fundamental","pubTime":"2025-02-18 19:25","pubTimestamp":1739877934,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Vanda (VNDA – Research Report) today and set a price target of $20.00. Ram Selvara...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/vanda-pharmaceuticals-promising-revenue-growth-and-strategic-pipeline-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/vanda-pharmaceuticals-promising-revenue-growth-and-strategic-pipeline-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VNDA"],"gpt_icon":0},{"id":"2511418356","title":"Vanda Pharmaceuticals’ Earnings Call: Mixed Results and Future Optimism","url":"https://stock-news.laohu8.com/highlight/detail?id=2511418356","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511418356?lang=en_us&edition=fundamental","pubTime":"2025-02-15 08:02","pubTimestamp":1739577726,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals (($VNDA)) has held its Q4 earnings call. Read on for the main highlights of the call. The latest earnings call from Vanda Pha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vanda-pharmaceuticals-earnings-call-mixed-results-and-future-optimism?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vanda-pharmaceuticals-earnings-call-mixed-results-and-future-optimism?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VNDA"],"gpt_icon":0},{"id":"2511630155","title":"Vanda Pharmaceuticals Inc (VNDA) Q4 2024 Earnings Call Highlights: Revenue Growth Amidst Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2511630155","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511630155?lang=en_us&edition=fundamental","pubTime":"2025-02-14 15:20","pubTimestamp":1739517641,"startTime":"0","endTime":"0","summary":"Total Revenue : $198.8 million, a 3% increase from $192.6 million in 2023.Fanapt Net Product Sales : $94.3 million, a 4% increase from $90.9 million in 2023.HETLIOZ Net Product Sales : $76.7 million, a 23% decrease from $100.2 million in 2023.Net Loss : $18.9 million compared to net income of $2.5 million in 2023.Operating Expenses : $239.4 million, up from $206.6 million in 2023.Cash, Cash Equivalents, and Marketable Securities : $374.6 million.Total Revenue : $53.2 million, a 17% increase from $45.3 million in Q4 2023.Fanapt Net Product Sales : $26.6 million, an 18% increase from $22.6 million in Q4 2023.HETLIOZ Net Product Sales : $20 million, a 5% decrease from $21.1 million in Q4 2023.GuruFocus has detected 4 Warning Signs with VNDA.For the complete transcript of the earnings call, please refer to the full earnings call transcript.Operating expenses increased by $32.8 million in 2024, primarily driven by higher SG&A expenses related to commercial launches and legal activities.Vand","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vanda-pharmaceuticals-inc-vnda-q4-072041773.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VNDA"],"gpt_icon":0},{"id":"2511050412","title":"Vanda Pharmaceuticals (VNDA) Reports Q4 Loss, Tops Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2511050412","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511050412?lang=en_us&edition=fundamental","pubTime":"2025-02-14 06:15","pubTimestamp":1739484909,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals  came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.04 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 42.86%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of $0.17 per share when it actually produced a loss of $0.09, delivering a surprise of 47.06%.Over the last four quarters, the company has surpassed consensus EPS estimates two times.Vanda , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $53.19 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 4.28%. This compares to year-ago revenues of $45.27 million. The company has topped consensus revenue estimates two times over the last four quarters.Investors should be mindful of the fact that the outlook for the industry can have a materi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vanda-pharmaceuticals-vnda-reports-q4-221509234.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VNDA"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":81,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VNDA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-07","symbol":"VNDA","fiscalQuarterEnding":"2025/03","expectedEps":-0.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"post","actualEps":-0.5},{"market":"US","date":"2025-02-13","symbol":"VNDA","fiscalQuarterEnding":"2024/12","expectedEps":-0.14,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739422800000,"reportTimeType":"post","actualEps":-0.08},{"market":"US","date":"2024-11-06","symbol":"VNDA","fiscalQuarterEnding":"2024/09","expectedEps":-0.17,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":-0.09},{"market":"US","date":"2024-07-31","symbol":"VNDA","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1722398400000,"reportTimeType":"post","actualEps":-0.08},{"market":"US","date":"2024-05-08","symbol":"VNDA","fiscalQuarterEnding":"2024/03","expectedEps":0.05,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"post","actualEps":-0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VNDA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VNDA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6667,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1730433600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VNDA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VNDA","date":"2025-06-18","current":-5.980289,"percent":0.197684,"low":-77.375491,"twenty":-5.860417,"median":26.113076,"eighty":50.47466,"high":127.111916,"avg":24.17569,"sd":35.033515,"marketCap":264615824},"quantilePoints":[{"date":"2020-06-26","current":5.214166,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":608237640},{"date":"2020-07-02","current":5.541512,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":646422962},{"date":"2020-07-10","current":5.373163,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":626784796},{"date":"2020-07-17","current":5.228195,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":609874153},{"date":"2020-07-24","current":4.952288,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":577689381},{"date":"2020-07-31","current":4.713793,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":549868646},{"date":"2020-08-07","current":5.760915,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":655816788},{"date":"2020-08-14","current":5.60249,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":637781826},{"date":"2020-08-21","current":5.117613,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":582583913},{"date":"2020-08-28","current":4.971189,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":565915236},{"date":"2020-09-04","current":4.925582,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":560723353},{"date":"2020-09-11","current":4.675943,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":532304626},{"date":"2020-09-18","current":4.728751,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":538316280},{"date":"2020-09-25","current":4.474311,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":509351038},{"date":"2020-10-02","current":4.690345,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":533944168},{"date":"2020-10-09","current":5.266436,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":599525847},{"date":"2020-10-16","current":5.180023,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":589688595},{"date":"2020-10-23","current":4.920781,"twenty":-17.144215,"median":5.87073,"eighty":28.808541,"marketCap":560176839},{"date":"2020-10-30","current":30.19438,"twenty":-17.144215,"median":5.899218,"eighty":29.694964,"marketCap":584653781},{"date":"2020-11-06","current":33.117784,"twenty":-17.144215,"median":6.154515,"eighty":30.889744,"marketCap":641259643},{"date":"2020-11-13","current":37.19925,"twenty":-17.144215,"median":6.554443,"eighty":31.992923,"marketCap":720289083},{"date":"2020-11-20","current":34.911369,"twenty":-17.144215,"median":6.62676,"eighty":32.919643,"marketCap":675988843},{"date":"2020-11-27","current":35.052596,"twenty":-17.144215,"median":6.775773,"eighty":33.264042,"marketCap":678723426},{"date":"2020-12-04","current":37.707668,"twenty":-17.144215,"median":6.845898,"eighty":33.583841,"marketCap":730133580},{"date":"2020-12-11","current":36.083555,"twenty":-17.144215,"median":7.118726,"eighty":34.102745,"marketCap":698685879},{"date":"2020-12-18","current":39.006959,"twenty":-17.144215,"median":7.203095,"eighty":34.28248,"marketCap":755291741},{"date":"2020-12-24","current":37.50995,"twenty":-17.144215,"median":7.30609,"eighty":34.52533,"marketCap":726305165},{"date":"2020-12-31","current":37.114514,"twenty":-17.144215,"median":7.332386,"eighty":34.679035,"marketCap":718648333},{"date":"2021-01-08","current":38.978713,"twenty":-17.144215,"median":7.417851,"eighty":34.913039,"marketCap":754744825},{"date":"2021-01-15","current":38.780995,"twenty":-17.144215,"median":7.501124,"eighty":35.145052,"marketCap":750916409},{"date":"2021-01-22","current":40.108531,"twenty":-17.144215,"median":7.631511,"eighty":35.920836,"marketCap":776621486},{"date":"2021-01-29","current":40.503967,"twenty":-17.144215,"median":9.691848,"eighty":36.113637,"marketCap":784278318},{"date":"2021-02-05","current":42.820094,"twenty":-17.144215,"median":9.973445,"eighty":36.379702,"marketCap":829125474},{"date":"2021-02-12","current":42.87234,"twenty":-17.144215,"median":10.161149,"eighty":36.651009,"marketCap":1000511803},{"date":"2021-02-19","current":43.977661,"twenty":-17.144215,"median":10.195815,"eighty":36.786867,"marketCap":1026306677},{"date":"2021-02-26","current":43.860074,"twenty":-17.144215,"median":10.351377,"eighty":36.95069,"marketCap":1023562541},{"date":"2021-03-05","current":42.907616,"twenty":-17.154068,"median":10.647105,"eighty":37.165355,"marketCap":1001335043},{"date":"2021-03-12","current":42.119781,"twenty":-17.154068,"median":11.30316,"eighty":37.398806,"marketCap":982949336},{"date":"2021-03-19","current":41.085013,"twenty":-17.154068,"median":11.789039,"eighty":37.50995,"marketCap":958800943},{"date":"2021-03-26","current":36.38152,"twenty":-17.144215,"median":12.283231,"eighty":37.538196,"marketCap":849035523},{"date":"2021-04-01","current":36.945939,"twenty":-17.144215,"median":12.510069,"eighty":37.538196,"marketCap":862207374},{"date":"2021-04-09","current":38.215882,"twenty":-17.154068,"median":12.594144,"eighty":37.651054,"marketCap":891844037},{"date":"2021-04-16","current":39.203616,"twenty":-17.154068,"median":12.774882,"eighty":37.912898,"marketCap":914894775},{"date":"2021-04-23","current":40.403255,"twenty":-17.154068,"median":12.824175,"eighty":38.140123,"marketCap":942890771},{"date":"2021-04-30","current":39.522336,"twenty":-17.154068,"median":12.914543,"eighty":38.320951,"marketCap":922332752},{"date":"2021-05-07","current":31.503027,"twenty":-17.154068,"median":12.991494,"eighty":38.326403,"marketCap":992376862},{"date":"2021-05-14","current":32.896498,"twenty":-17.154068,"median":13.029375,"eighty":38.326403,"marketCap":1036272591},{"date":"2021-05-21","current":32.614276,"twenty":-17.154068,"median":13.095281,"eighty":38.326403,"marketCap":1027382316},{"date":"2021-05-28","current":31.203166,"twenty":-17.154068,"median":13.194903,"eighty":38.326403,"marketCap":982930945},{"date":"2021-06-04","current":31.92636,"twenty":-17.154068,"median":13.218512,"eighty":38.326403,"marketCap":1005712273},{"date":"2021-06-11","current":33.831358,"twenty":-17.154068,"median":13.226727,"eighty":38.326403,"marketCap":1065721624},{"date":"2021-06-18","current":33.81372,"twenty":-17.154068,"median":13.259589,"eighty":38.326403,"marketCap":1065165982},{"date":"2021-06-25","current":36.653578,"twenty":-17.154068,"median":13.335965,"eighty":38.326403,"marketCap":1154624366},{"date":"2021-07-02","current":36.724134,"twenty":-17.154068,"median":13.357957,"eighty":38.326403,"marketCap":1156846935},{"date":"2021-07-09","current":36.194967,"twenty":-17.154068,"median":13.357957,"eighty":38.326403,"marketCap":1140177671},{"date":"2021-07-16","current":33.390387,"twenty":-17.154068,"median":13.385175,"eighty":38.326403,"marketCap":1051830571},{"date":"2021-07-23","current":34.642747,"twenty":-17.154068,"median":13.434386,"eighty":38.326403,"marketCap":1091281162},{"date":"2021-07-30","current":27.973443,"twenty":-17.154068,"median":13.483596,"eighty":38.326403,"marketCap":907458487},{"date":"2021-08-06","current":27.441759,"twenty":-17.154068,"median":13.631226,"eighty":38.326403,"marketCap":890210656},{"date":"2021-08-13","current":28.24786,"twenty":-17.154068,"median":13.670356,"eighty":38.326403,"marketCap":916360594},{"date":"2021-08-20","current":27.115888,"twenty":-17.154068,"median":13.75522,"eighty":38.326403,"marketCap":879639404},{"date":"2021-08-27","current":29.6371,"twenty":-17.154068,"median":13.826448,"eighty":38.326403,"marketCap":961427508},{"date":"2021-09-03","current":28.71094,"twenty":-17.154068,"median":13.854535,"eighty":38.326403,"marketCap":931382898},{"date":"2021-09-10","current":27.76763,"twenty":-17.154068,"median":13.953851,"eighty":38.326403,"marketCap":900781907},{"date":"2021-09-17","current":29.071113,"twenty":-17.154068,"median":14.053167,"eighty":38.326403,"marketCap":943066913},{"date":"2021-09-24","current":29.602797,"twenty":-17.154068,"median":14.081124,"eighty":38.326403,"marketCap":960314745},{"date":"2021-10-01","current":30.494654,"twenty":-17.154068,"median":14.152482,"eighty":38.326403,"marketCap":989246591},{"date":"2021-10-08","current":31.026339,"twenty":-17.154068,"median":14.270959,"eighty":38.326403,"marketCap":1006494422},{"date":"2021-10-15","current":31.575174,"twenty":-17.154068,"median":14.301456,"eighty":38.326403,"marketCap":1024298636},{"date":"2021-10-22","current":31.386512,"twenty":-17.154068,"median":14.351114,"eighty":38.326403,"marketCap":1018178437},{"date":"2021-10-29","current":29.362682,"twenty":-17.154068,"median":14.4678,"eighty":38.326403,"marketCap":952525401},{"date":"2021-11-05","current":29.12112,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":997806039},{"date":"2021-11-12","current":28.877224,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":989449204},{"date":"2021-11-19","current":27.576448,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":944879420},{"date":"2021-11-26","current":26.909801,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":922037406},{"date":"2021-12-03","current":26.373231,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":903652370},{"date":"2021-12-10","current":25.706583,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":880810356},{"date":"2021-12-17","current":27.153696,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":930394241},{"date":"2021-12-23","current":29.234937,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":1001705895},{"date":"2021-12-31","current":25.511466,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":874124888},{"date":"2022-01-07","current":25.007416,"twenty":-17.144215,"median":14.807432,"eighty":38.3263,"marketCap":856854097},{"date":"2022-01-14","current":24.389547,"twenty":-17.144215,"median":14.956751,"eighty":38.3263,"marketCap":835683450},{"date":"2022-01-21","current":23.072512,"twenty":-17.144215,"median":18.908459,"eighty":38.3263,"marketCap":790556543},{"date":"2022-01-28","current":23.966795,"twenty":-17.144215,"median":23.183837,"eighty":38.3263,"marketCap":821198270},{"date":"2022-02-04","current":19.560417,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":670218126},{"date":"2022-02-11","current":21.983112,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":753229349},{"date":"2022-02-18","current":21.804255,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":747101004},{"date":"2022-02-25","current":18.853723,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":625038638},{"date":"2022-03-04","current":18.280354,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":606030308},{"date":"2022-03-11","current":18.786268,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":622802364},{"date":"2022-03-18","current":20.287146,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":672559465},{"date":"2022-03-25","current":19.32591,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":640692558},{"date":"2022-04-01","current":19.94987,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":661378094},{"date":"2022-04-08","current":19.916143,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":660259957},{"date":"2022-04-14","current":19.157272,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":635101872},{"date":"2022-04-22","current":18.448992,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":611620993},{"date":"2022-04-29","current":16.903143,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":560372983},{"date":"2022-05-06","current":30.007815,"twenty":-17.144215,"median":23.81234,"eighty":38.3263,"marketCap":542301235},{"date":"2022-05-13","current":31.289399,"twenty":-17.144215,"median":23.974925,"eighty":38.3263,"marketCap":565462017},{"date":"2022-05-20","current":31.008076,"twenty":-17.144215,"median":24.499553,"eighty":38.3263,"marketCap":560377943},{"date":"2022-05-27","current":31.94582,"twenty":-17.144215,"median":24.726466,"eighty":38.3263,"marketCap":577324856},{"date":"2022-06-03","current":31.727013,"twenty":-17.144215,"median":24.881125,"eighty":38.3263,"marketCap":573370576},{"date":"2022-06-10","current":30.539204,"twenty":-17.144215,"median":25.073094,"eighty":38.3263,"marketCap":551904486},{"date":"2022-06-17","current":29.914041,"twenty":-17.144215,"median":25.293157,"eighty":38.3263,"marketCap":540606543},{"date":"2022-06-24","current":33.446211,"twenty":-17.154068,"median":25.452351,"eighty":38.326403,"marketCap":604439918},{"date":"2022-07-01","current":34.97786,"twenty":-17.101725,"median":25.564724,"eighty":38.326403,"marketCap":632119877},{"date":"2022-07-08","current":36.759574,"twenty":-17.02494,"median":25.639639,"eighty":38.326403,"marketCap":664319013},{"date":"2022-07-15","current":35.853087,"twenty":-16.800559,"median":25.706583,"eighty":38.326403,"marketCap":647936996},{"date":"2022-07-22","current":34.29018,"twenty":-16.579017,"median":26.014214,"eighty":38.326403,"marketCap":619692140},{"date":"2022-07-29","current":33.696276,"twenty":-15.600428,"median":26.267051,"eighty":38.326403,"marketCap":608959095},{"date":"2022-08-05","current":54.282127,"twenty":3.791287,"median":26.340711,"eighty":38.356987,"marketCap":596723424},{"date":"2022-08-12","current":53.561796,"twenty":4.32242,"median":26.426246,"eighty":38.538084,"marketCap":588804819},{"date":"2022-08-19","current":53.253082,"twenty":4.487703,"median":26.576076,"eighty":38.789104,"marketCap":585411131},{"date":"2022-08-26","current":52.73856,"twenty":4.580888,"median":26.909801,"eighty":38.878336,"marketCap":579754985},{"date":"2022-09-02","current":53.407439,"twenty":4.668262,"median":27.104917,"eighty":38.971271,"marketCap":587107975},{"date":"2022-09-09","current":52.944369,"twenty":4.722768,"median":27.300033,"eighty":39.099148,"marketCap":582017443},{"date":"2022-09-16","current":51.246444,"twenty":4.761973,"median":27.45891,"eighty":39.345148,"marketCap":563352161},{"date":"2022-09-23","current":49.754329,"twenty":4.810183,"median":27.630421,"eighty":39.443307,"marketCap":546949337},{"date":"2022-09-30","current":50.834826,"twenty":4.836812,"median":27.76763,"eighty":39.543622,"marketCap":558827244},{"date":"2022-10-07","current":50.783374,"twenty":4.921115,"median":27.924545,"eighty":39.763436,"marketCap":558261629},{"date":"2022-10-14","current":50.47466,"twenty":4.941755,"median":28.024896,"eighty":39.984463,"marketCap":554867942},{"date":"2022-10-21","current":53.355987,"twenty":4.983255,"median":28.178057,"eighty":40.08767,"marketCap":586542360},{"date":"2022-10-28","current":54.590841,"twenty":5.012956,"median":28.291875,"eighty":40.302998,"marketCap":600117111},{"date":"2022-11-04","current":91.788849,"twenty":5.062961,"median":28.448949,"eighty":40.563626,"marketCap":595893205},{"date":"2022-11-11","current":93.27072,"twenty":5.093819,"median":28.590882,"eighty":40.972842,"marketCap":605513513},{"date":"2022-11-18","current":93.096382,"twenty":5.117101,"median":28.71094,"eighty":41.160269,"marketCap":604381712},{"date":"2022-11-25","current":90.91716,"twenty":5.138736,"median":28.748609,"eighty":41.266594,"marketCap":590234200},{"date":"2022-12-02","current":95.101267,"twenty":5.157046,"median":28.985358,"eighty":41.937708,"marketCap":617397423},{"date":"2022-12-09","current":91.614511,"twenty":5.176833,"median":29.071113,"eighty":42.119781,"marketCap":594761404},{"date":"2022-12-16","current":61.454072,"twenty":5.208554,"median":29.234937,"eighty":42.368145,"marketCap":398959838},{"date":"2022-12-23","current":59.885032,"twenty":5.239077,"median":29.511352,"eighty":43.046766,"marketCap":388773629},{"date":"2022-12-30","current":64.417815,"twenty":5.255617,"median":29.543872,"eighty":43.602452,"marketCap":418200454},{"date":"2023-01-06","current":64.679322,"twenty":5.277282,"median":29.6371,"eighty":43.9356,"marketCap":419898156},{"date":"2023-01-13","current":66.858544,"twenty":5.292197,"median":30.070331,"eighty":44.079494,"marketCap":434045668},{"date":"2023-01-20","current":65.725348,"twenty":5.315176,"median":30.184129,"eighty":48.044423,"marketCap":426688961},{"date":"2023-01-27","current":66.684206,"twenty":5.339308,"median":30.476687,"eighty":49.929267,"marketCap":432913867},{"date":"2023-02-03","current":66.684206,"twenty":5.359134,"median":30.528529,"eighty":50.515822,"marketCap":432913867},{"date":"2023-02-10","current":65.789461,"twenty":5.371292,"median":30.60172,"eighty":50.989183,"marketCap":412828869},{"date":"2023-02-17","current":63.889078,"twenty":5.395729,"median":30.726752,"eighty":51.812419,"marketCap":400903963},{"date":"2023-02-24","current":58.549906,"twenty":5.423851,"median":30.872928,"eighty":52.172585,"marketCap":367400658},{"date":"2023-03-03","current":57.644961,"twenty":5.475409,"median":30.940583,"eighty":52.779722,"marketCap":361722131},{"date":"2023-03-10","current":56.106556,"twenty":5.507294,"median":31.026339,"eighty":52.96495,"marketCap":352068636},{"date":"2023-03-17","current":59.002378,"twenty":5.539642,"median":31.129245,"eighty":53.139887,"marketCap":370239921},{"date":"2023-03-24","current":61.08375,"twenty":5.565634,"median":31.256083,"eighty":53.407439,"marketCap":383300532},{"date":"2023-03-31","current":61.445728,"twenty":5.591919,"median":31.406014,"eighty":53.726443,"marketCap":385571942},{"date":"2023-04-06","current":61.08375,"twenty":5.638122,"median":31.503027,"eighty":53.89109,"marketCap":383300532},{"date":"2023-04-14","current":62.803145,"twenty":5.715788,"median":31.776429,"eighty":54.282127,"marketCap":394089732},{"date":"2023-04-21","current":56.016061,"twenty":5.800167,"median":31.94582,"eighty":55.571109,"marketCap":351500784},{"date":"2023-04-28","current":56.757062,"twenty":5.889576,"median":32.228692,"eighty":56.160852,"marketCap":356150561},{"date":"2023-05-05","current":24.731543,"twenty":6.039467,"median":32.415379,"eighty":56.342329,"marketCap":394641234},{"date":"2023-05-12","current":22.319588,"twenty":6.525956,"median":32.447324,"eighty":56.360184,"marketCap":356153661},{"date":"2023-05-19","current":21.995594,"twenty":6.590821,"median":32.447324,"eighty":56.360184,"marketCap":350983689},{"date":"2023-05-26","current":21.563602,"twenty":6.773144,"median":32.447324,"eighty":56.360184,"marketCap":344090392},{"date":"2023-06-01","current":21.419604,"twenty":6.793305,"median":32.447324,"eighty":56.360184,"marketCap":341792627},{"date":"2023-06-09","current":23.399568,"twenty":7.081692,"median":32.455526,"eighty":56.453844,"marketCap":373386903},{"date":"2023-06-16","current":22.823578,"twenty":7.191261,"median":32.455526,"eighty":56.453844,"marketCap":364195841},{"date":"2023-06-23","current":23.147572,"twenty":7.30346,"median":32.473165,"eighty":56.605453,"marketCap":369365813},{"date":"2023-06-30","current":23.975557,"twenty":7.332386,"median":32.537703,"eighty":56.681257,"marketCap":382577965},{"date":"2023-07-07","current":23.651563,"twenty":7.360874,"median":32.602241,"eighty":56.757062,"marketCap":377407993},{"date":"2023-07-14","current":21.707599,"twenty":7.488413,"median":32.608258,"eighty":56.771752,"marketCap":346388158},{"date":"2023-07-21","current":23.039574,"twenty":7.560291,"median":32.653799,"eighty":56.801131,"marketCap":367642489},{"date":"2023-07-28","current":24.900298,"twenty":17.199629,"median":32.693323,"eighty":56.815821,"marketCap":371089137},{"date":"2023-08-04","current":21.763998,"twenty":17.370024,"median":32.473165,"eighty":56.272572,"marketCap":324348859},{"date":"2023-08-11","current":23.230366,"twenty":17.370024,"median":32.261499,"eighty":55.997962,"marketCap":346202151},{"date":"2023-08-18","current":22.535771,"twenty":17.370024,"median":31.94582,"eighty":54.55997,"marketCap":335850591},{"date":"2023-08-25","current":22.034118,"twenty":17.370024,"median":31.802888,"eighty":54.096899,"marketCap":328374465},{"date":"2023-09-01","current":20.027509,"twenty":17.370024,"median":31.503027,"eighty":53.757314,"marketCap":298469960},{"date":"2023-09-08","current":17.635012,"twenty":17.239057,"median":31.414833,"eighty":53.448601,"marketCap":262814589},{"date":"2023-09-15","current":18.329608,"twenty":17.226892,"median":31.272741,"eighty":53.253082,"marketCap":273166149},{"date":"2023-09-22","current":17.210537,"twenty":16.940417,"median":31.137821,"eighty":52.995821,"marketCap":256488636},{"date":"2023-09-29","current":16.824651,"twenty":16.932962,"median":31.041743,"eighty":52.851754,"marketCap":250737770},{"date":"2023-10-06","current":17.210537,"twenty":16.732038,"median":30.974885,"eighty":52.316651,"marketCap":256488636},{"date":"2023-10-13","current":16.747473,"twenty":16.670296,"median":30.914301,"eighty":52.06968,"marketCap":249587597},{"date":"2023-10-20","current":16.631708,"twenty":16.608555,"median":30.837677,"eighty":51.246444,"marketCap":247862337},{"date":"2023-10-27","current":16.940417,"twenty":16.539095,"median":30.726752,"eighty":50.824536,"marketCap":252463030},{"date":"2023-11-02","current":16.863239,"twenty":16.11462,"median":30.60172,"eighty":50.454079,"marketCap":251312857},{"date":"2023-11-10","current":16.521509,"twenty":16.014289,"median":30.520167,"eighty":49.754329,"marketCap":194458156},{"date":"2023-11-17","current":16.521509,"twenty":16.014289,"median":30.468519,"eighty":44.73022,"marketCap":194458156},{"date":"2023-11-24","current":17.401352,"twenty":16.014289,"median":30.189254,"eighty":43.977661,"marketCap":204813916},{"date":"2023-12-01","current":18.183436,"twenty":16.014289,"median":30.039073,"eighty":43.860074,"marketCap":214019036},{"date":"2023-12-08","current":19.405441,"twenty":16.11462,"median":29.6371,"eighty":43.094886,"marketCap":228402036},{"date":"2023-12-15","current":18.818878,"twenty":16.014289,"median":29.535742,"eighty":42.820094,"marketCap":221498196},{"date":"2023-12-21","current":18.574477,"twenty":15.983418,"median":29.511352,"eighty":42.218766,"marketCap":218621596},{"date":"2023-12-27","current":19.796482,"twenty":15.967983,"median":29.362682,"eighty":42.119781,"marketCap":233004595},{"date":"2024-01-05","current":20.676326,"twenty":14.280594,"median":29.131142,"eighty":41.900534,"marketCap":243360355},{"date":"2024-01-12","current":19.16104,"twenty":14.280594,"median":29.033964,"eighty":41.266594,"marketCap":225525436},{"date":"2024-01-19","current":18.036795,"twenty":12.624076,"median":28.933904,"eighty":41.111092,"marketCap":212293076},{"date":"2024-01-26","current":18.525597,"twenty":14.280594,"median":28.73835,"eighty":40.950245,"marketCap":218046276},{"date":"2024-02-02","current":18.232316,"twenty":14.280594,"median":28.702365,"eighty":40.554867,"marketCap":214594356},{"date":"2024-02-09","current":93.335042,"twenty":14.280594,"median":28.628365,"eighty":40.422302,"marketCap":234177620},{"date":"2024-02-16","current":100.214775,"twenty":14.280594,"median":28.628365,"eighty":40.499585,"marketCap":251438870},{"date":"2024-02-23","current":99.297477,"twenty":14.280594,"median":28.628365,"eighty":40.499585,"marketCap":249137370},{"date":"2024-03-01","current":102.508019,"twenty":15.937112,"median":28.665848,"eighty":40.503967,"marketCap":257192620},{"date":"2024-03-08","current":87.601931,"twenty":15.937112,"median":28.665848,"eighty":40.589905,"marketCap":219793246},{"date":"2024-03-15","current":87.143283,"twenty":15.937112,"median":28.665848,"eighty":41.040631,"marketCap":218642496},{"date":"2024-03-22","current":89.665851,"twenty":15.937112,"median":28.665848,"eighty":41.2026,"marketCap":224971621},{"date":"2024-03-28","current":89.207202,"twenty":15.937112,"median":28.665848,"eighty":41.767019,"marketCap":223820871},{"date":"2024-04-05","current":112.827619,"twenty":14.280594,"median":28.628365,"eighty":42.195037,"marketCap":283084495},{"date":"2024-04-12","current":98.150855,"twenty":14.280594,"median":28.628365,"eighty":43.126328,"marketCap":246260495},{"date":"2024-04-19","current":113.974241,"twenty":14.280594,"median":28.628365,"eighty":43.954144,"marketCap":285961370},{"date":"2024-04-26","current":102.737344,"twenty":15.937112,"median":28.665848,"eighty":44.091139,"marketCap":257767995},{"date":"2024-05-03","current":108.555431,"twenty":15.937112,"median":28.665848,"eighty":49.033997,"marketCap":272365577},{"date":"2024-05-10","current":-59.638647,"twenty":7.636989,"median":28.55658,"eighty":49.908686,"marketCap":291573347},{"date":"2024-05-17","current":-66.423883,"twenty":7.498932,"median":28.385069,"eighty":49.908686,"marketCap":324746363},{"date":"2024-05-24","current":-58.448255,"twenty":7.393745,"median":28.282163,"eighty":49.908686,"marketCap":285753520},{"date":"2024-05-31","current":-59.638647,"twenty":7.332386,"median":28.178057,"eighty":49.908686,"marketCap":291573347},{"date":"2024-06-07","current":-74.637589,"twenty":7.30609,"median":28.024896,"eighty":49.908686,"marketCap":364903171},{"date":"2024-06-14","current":-77.375491,"twenty":7.19915,"median":27.948994,"eighty":49.918976,"marketCap":378288774},{"date":"2024-06-21","current":-71.125932,"twenty":7.118945,"median":27.784781,"eighty":49.929267,"marketCap":347734681},{"date":"2024-06-28","current":-69.161785,"twenty":7.043123,"median":27.699025,"eighty":49.960138,"marketCap":338131966},{"date":"2024-07-05","current":-63.80502,"twenty":6.810836,"median":27.600837,"eighty":49.960138,"marketCap":311942743},{"date":"2024-07-12","current":-69.042746,"twenty":6.637716,"median":27.435935,"eighty":49.960138,"marketCap":337549983},{"date":"2024-07-15","current":-70.471216,"twenty":6.635525,"median":27.384481,"eighty":49.960138,"marketCap":344533776},{"date":"2024-08-02","current":-30.086439,"twenty":6.577672,"median":27.104917,"eighty":50.433498,"marketCap":328754517},{"date":"2024-08-09","current":-28.326062,"twenty":6.484758,"median":26.909801,"eighty":50.433498,"marketCap":309518880},{"date":"2024-08-16","current":-27.579236,"twenty":5.966713,"median":26.576076,"eighty":50.433498,"marketCap":301358307},{"date":"2024-08-23","current":-28.272717,"twenty":5.88344,"median":26.426246,"eighty":50.433498,"marketCap":308935982},{"date":"2024-08-30","current":-27.845959,"twenty":5.768902,"median":26.340711,"eighty":50.433498,"marketCap":304272797},{"date":"2024-09-06","current":-27.099133,"twenty":5.715788,"median":26.332602,"eighty":50.433498,"marketCap":296112224},{"date":"2024-09-13","current":-26.61903,"twenty":5.655719,"median":26.295145,"eighty":50.433498,"marketCap":290866141},{"date":"2024-09-20","current":-24.805309,"twenty":5.58998,"median":26.295145,"eighty":50.433498,"marketCap":271047607},{"date":"2024-09-27","current":-25.285411,"twenty":5.563517,"median":26.295145,"eighty":50.433498,"marketCap":276293689},{"date":"2024-10-04","current":-24.005137,"twenty":5.528419,"median":26.295145,"eighty":50.433498,"marketCap":262304136},{"date":"2024-10-11","current":-23.525035,"twenty":5.491943,"median":26.295145,"eighty":50.433498,"marketCap":257058053},{"date":"2024-10-18","current":-25.258739,"twenty":5.461327,"median":26.295145,"eighty":50.433498,"marketCap":276002240},{"date":"2024-10-25","current":-24.111827,"twenty":5.418839,"median":26.295145,"eighty":50.433498,"marketCap":263469932},{"date":"2024-10-31","current":-24.325206,"twenty":5.391868,"median":26.014214,"eighty":50.433498,"marketCap":265801524},{"date":"2024-11-08","current":-17.855433,"twenty":5.367499,"median":26.015518,"eighty":50.454079,"marketCap":292614836},{"date":"2024-11-15","current":-18.145688,"twenty":5.359134,"median":26.015518,"eighty":50.454079,"marketCap":297371534},{"date":"2024-11-22","current":-17.576411,"twenty":5.328527,"median":26.015518,"eighty":50.454079,"marketCap":288042231},{"date":"2024-11-29","current":-18.323587,"twenty":5.313305,"median":26.015518,"eighty":50.454079,"marketCap":300286941},{"date":"2024-12-06","current":-17.007135,"twenty":5.288291,"median":26.015518,"eighty":50.454079,"marketCap":278712928},{"date":"2024-12-13","current":-16.437858,"twenty":5.274959,"median":26.015518,"eighty":50.454079,"marketCap":269383625},{"date":"2024-12-20","current":-16.473438,"twenty":5.247835,"median":26.015518,"eighty":50.454079,"marketCap":269966706},{"date":"2024-12-27","current":-17.113874,"twenty":5.219777,"median":26.015518,"eighty":50.454079,"marketCap":280462172},{"date":"2025-01-03","current":-17.149454,"twenty":5.200137,"median":26.015518,"eighty":50.454079,"marketCap":281045254},{"date":"2025-01-10","current":-16.544598,"twenty":5.172047,"median":26.048037,"eighty":50.47466,"marketCap":271132869},{"date":"2025-01-17","current":-15.797422,"twenty":5.151955,"median":26.048037,"eighty":50.47466,"marketCap":258888159},{"date":"2025-01-24","current":-15.726263,"twenty":5.141617,"median":26.048037,"eighty":50.47466,"marketCap":257721996},{"date":"2025-01-31","current":-16.295539,"twenty":5.116334,"median":26.048037,"eighty":50.47466,"marketCap":267051299},{"date":"2025-02-07","current":-16.686917,"twenty":5.087903,"median":26.048037,"eighty":50.47466,"marketCap":273465195},{"date":"2025-02-14","current":-14.499909,"twenty":5.060621,"median":26.048037,"eighty":50.47466,"marketCap":274048276},{"date":"2025-02-21","current":-13.853917,"twenty":5.016797,"median":26.048037,"eighty":50.47466,"marketCap":261839037},{"date":"2025-02-28","current":-14.501873,"twenty":4.989699,"median":26.048037,"eighty":50.47466,"marketCap":274085406},{"date":"2025-03-07","current":-15.149829,"twenty":4.942936,"median":26.113076,"eighty":50.47466,"marketCap":286331776},{"date":"2025-03-14","current":-15.180684,"twenty":4.942346,"median":26.113076,"eighty":50.47466,"marketCap":286914936},{"date":"2025-03-21","current":-15.180684,"twenty":4.942346,"median":26.113076,"eighty":50.47466,"marketCap":286914936},{"date":"2025-03-28","current":-14.193323,"twenty":4.942346,"median":26.113076,"eighty":50.47466,"marketCap":268253802},{"date":"2025-04-04","current":-13.483657,"twenty":4.939984,"median":26.113076,"eighty":50.47466,"marketCap":254841112},{"date":"2025-04-11","current":-12.58886,"twenty":4.887176,"median":26.048037,"eighty":50.47466,"marketCap":237929459},{"date":"2025-04-17","current":-13.483657,"twenty":4.834368,"median":26.048037,"eighty":50.47466,"marketCap":254841112},{"date":"2025-04-25","current":-13.298526,"twenty":4.763966,"median":26.113076,"eighty":50.47466,"marketCap":251342149},{"date":"2025-05-02","current":-13.844808,"twenty":4.709103,"median":26.113076,"eighty":50.47466,"marketCap":261666880},{"date":"2025-05-09","current":-5.620625,"twenty":4.634656,"median":26.113076,"eighty":50.47466,"marketCap":248701404},{"date":"2025-05-16","current":-5.234418,"twenty":4.508876,"median":26.113076,"eighty":50.47466,"marketCap":231612514},{"date":"2025-05-23","current":-5.647311,"twenty":-5.223763,"median":26.113076,"eighty":50.47466,"marketCap":249882203},{"date":"2025-05-30","current":-5.847098,"twenty":-5.402239,"median":26.113076,"eighty":50.47466,"marketCap":258722375},{"date":"2025-06-06","current":-5.847098,"twenty":-5.740545,"median":26.113076,"eighty":50.47466,"marketCap":258722375},{"date":"2025-06-13","current":-6.166757,"twenty":-5.793821,"median":26.113076,"eighty":50.47466,"marketCap":272866651},{"date":"2025-06-18","current":-5.980289,"twenty":-5.860417,"median":26.113076,"eighty":50.47466,"marketCap":264615824}],"updateTime":1750424906987}}}